Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q1)Dec 31, 2025 | (FY)Sep 30, 2025 | (Q4)Sep 30, 2025 | (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 30.59%-1.25M | -55.85%-5.42M | -357.80%-2.21M | 71.03%-419.34K | 10.31%-993.11K | -308.15%-1.8M | -103.04%-3.48M | 37.44%-482.46K | -90.98%-1.45M | -850.80%-1.11M |
| Net income from continuing operations | 19.51%-1.33M | 49.54%-6.37M | 84.73%-2.44M | 100.45%11.59K | -166.00%-2.29M | -166.84%-1.65M | -191.81%-12.62M | -363.79%-15.99M | -185.41%-2.57M | 97.87%3.46M |
| Operating gains losses | ---- | ---- | ---- | -182.09%-216.57K | 632.93%196.59K | 117.78%17.21K | 76.70%-52.25K | 19.12%-182.36K | 741.95%263.81K | -159.10%-36.89K |
| Depreciation and amortization | 10.32%153.69K | 52.60%522.29K | -68.31%108.45K | --137.26K | --137.26K | --139.31K | --342.27K | --342.27K | --0 | --0 |
| Asset impairment expenditure | ---- | --0 | ---- | ---- | ---- | ---- | 169.78%9.34M | ---- | ---- | ---- |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,373.82%1.05M | ---- |
| Remuneration paid in stock | 133.65%332.97K | 43.77%412.65K | -379.75%-380.75K | -28.46%112.41K | 789.81%538.48K | 98.33%142.51K | 92.52%287.03K | 353.57%136.1K | 266.04%157.13K | -224.35%-78.06K |
| Deferred tax | ---- | --0 | ---- | ---- | ---- | ---- | ---399K | ---- | ---- | ---- |
| Other non cashItems | -283.13%-414.01K | 594.13%1.27M | -86.39%857.15K | 108.72%490.35K | -113.15%-302.32K | 108.10%226.07K | 123.67%183.14K | 488.51%6.3M | -4,013.95%-5.62M | 291.69%2.3M |
| Change In working capital | 101.53%10.25K | -126.93%-1.26M | -1,360.07%-354.8K | 288.59%469K | -296.63%-701.25K | -543.49%-669.86K | -99,362.72%-553.89K | 92.80%-24.3K | -168.84%-248.69K | -132.29%-176.8K |
| -Change in receivables | ---- | -1,757.18%-96.98K | ---- | ---- | ---- | ---5.58K | 112.14%5.85K | ---- | ---- | 136.28%88.97K |
| -Change in inventory | ---- | -80.32%22.58K | ---- | ---- | ---- | --82.52K | --114.77K | ---- | ---- | ---- |
| -Change in prepaid assets | ---- | -183.40%-47.92K | ---- | ---- | ---- | -57.75%25.82K | 537.52%57.46K | ---- | ---- | -100.14%-1.2K |
| -Change in payables and accrued expense | ---- | -23.27%-411.26K | ---- | ---- | ---- | -169.98%-446.03K | -639.16%-333.63K | ---- | ---- | -480.22%-264.58K |
| -Change in other working capital | ---- | -81.59%-723.34K | ---- | ---- | ---- | ---326.58K | ---398.34K | ---- | ---- | ---- |
| Interest received (cash flow from operating activities) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---26.26K | ---- |
| Cash from discontinued investing activities | 0 | 0 | 139.06%183.8K | -588.36K | ||||||
| Operating cash flow | 22.70%-1.25M | -33.30%-5.42M | -106.26%-2.21M | 71.03%-419.34K | -85.84%-1.18M | -76.60%-1.62M | -137.38%-4.07M | -38.84%-1.07M | -90.98%-1.45M | -443.81%-633.29K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -304.64%-3.72M | 42.28%1.07M | 1.38M | 215.61%1.27M | -79.68%235.63K | -161.26%-919.22K | 752.07K | 0 | |
| Net intangibles purchas and sale | ---- | ---- | ---- | ---- | ---- | ---- | 14.22%1.32M | --169.51K | ---- | ---- |
| Net business purchase and sale | ---- | --0 | ---- | ---- | ---- | ---- | --235.63K | ---- | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | ---2.39M | --1.38M | 215.61%1.27M | --743.5K | ---- | ---- | --0 |
| Cash from discontinued investing activities | -96.85%40.02K | 367.19%9.66M | 1.27M | 2.07M | ||||||
| Investing cash flow | -96.85%40.02K | 319.40%9.66M | 417.25%5.94M | 42.28%1.07M | --1.38M | 215.61%1.27M | 98.66%2.3M | -23.45%1.15M | --752.07K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2,128.49%3.36M | -70.74%-489.5K | -66.03%-389.7K | 497.09%206.41K | -140.45K | -165.77K | 11.77%-286.7K | -1,036.45%-234.71K | -51.98K | 0 |
| Net issuance payments of debt | -638.36%-1.22M | -165.19%-760.27K | -12.03%-262.95K | -218.91%-165.77K | ---165.77K | ---165.77K | 18.09%-286.7K | ---234.71K | ---51.98K | --0 |
| Net common stock issuance | --3.16M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --1.84M | --397.52K | --0 | --372.19K | --25.33K | --0 | --0 | --0 | --0 | ---- |
| Net other financing activities | ---411.71K | ---126.75K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2,128.49%3.36M | -70.74%-489.5K | -66.03%-389.7K | 497.09%206.41K | ---140.45K | ---165.77K | 11.77%-286.7K | -1,036.45%-234.71K | ---51.98K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 260.31%5.19M | -58.72%1.44M | 15.71%1.85M | -57.72%991.71K | -68.75%930.81K | -58.72%1.44M | -40.20%3.49M | -62.68%1.6M | -53.08%2.35M | -45.72%2.98M |
| Current changes in cash | 522.23%2.15M | 283.00%3.75M | 2,230.58%3.34M | 214.67%857.16K | 109.62%60.9K | 0.37%-510.12K | 12.66%-2.05M | 78.03%-156.9K | 1.38%-747.48K | -38.44%-633.29K |
| End cash Position | 689.16%7.35M | 260.31%5.19M | 260.31%5.19M | 15.71%1.85M | -57.72%991.71K | -68.75%930.81K | -58.72%1.44M | -58.72%1.44M | -62.68%1.6M | -53.08%2.35M |
| Free cash from | 22.70%-1.25M | -33.30%-5.42M | -106.26%-2.21M | 71.03%-419.34K | -85.84%-1.18M | -76.60%-1.62M | -112.51%-4.07M | -10.19%-1.07M | -90.98%-1.45M | -443.81%-633.29K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.